An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Cancer is a heterogeneous disease caused by diverse genomic alterations in oncogenes and tumor suppressor genes. Despite recent advances in high-throughput sequencing technologies and development of targeted therapies, novel cancer drug development is limited due to the high attrition rate from clin...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Society for Molecular and Cellular Biology
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757806/ |